Valentina Pirazzoli

<i>HER2</i> Amplification: A Potential Mechanism of Acquired Resistance to EGFR Inhibition in <i>EGFR</i> -Mutant Lung Cancers That Lack the Second-Site <i>EGFR</i> T790M Mutation

Ken Takezawa, Valentina Pirazzoli, Maria E. Arcila et al. · Cancer Discovery · 2012 · 726 citations · Full text

Medicine, Oncology, Pharmacology +17

Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5

Andrea Taddei, Costanza Giampietro, Annarita Conti et al. · Nature Cell Biology · 2008 · 659 citations

Life Sciences, Cell Biology, Molecular Biology +12

Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy

Luca Zammataro, Salvatore Lopez, Stefania Bellone et al. · Proceedings of the National Academy of Sciences · 2019 · 94 citations · Full text

Medicine, Genetics, Oncology +17

Noncovalent Wild-type–Sparing Inhibitors of EGFR T790M

Ho‐June Lee, Gabriele Schaefer, Timothy P. Heffron et al. · Cancer Discovery · 2012 · 87 citations

Medicine, Oncology, Pharmacology +15

Acquired Resistance of EGFR-Mutant Lung Adenocarcinomas to Afatinib plus Cetuximab Is Associated with Activation of mTORC1

Valentina Pirazzoli, Caroline A. Nebhan, Xiaoling Song et al. · Cell Reports · 2014 · 72 citations · Full text

Medicine, Oncology, Pharmacology +17